These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31071252)

  • 1. [Serological screening in donors in Mexico: advances and technology].
    Ayala-De la Cruz S; Flores-Aréchiga A; Llaca-Díaz J; Pérez-Chávez F; Salazar-Montalvo RG; Casillas-Vega N
    Rev Med Inst Mex Seguro Soc; 2019 Apr; 57(1):30-35. PubMed ID: 31071252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
    Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
    Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fifteen years of Nucleic Acid Testing in France: Results and lessons.
    Laperche S; Tiberghien P; Roche-Longin C; Pillonel J
    Transfus Clin Biol; 2017 Sep; 24(3):182-188. PubMed ID: 28709845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the risk of transfusion-transmitted syphilis: a reconsideration of blood donation testing strategies.
    Jayawardena T; Hoad V; Styles C; Seed C; Bentley P; Clifford V; Lacey S; Gastrell T
    Vox Sang; 2019 Feb; 114(2):107-116. PubMed ID: 30565234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of pre-donation viral markers screening of new blood donors on blood safety.
    Ferdowsi S; Maghsudlu M; Pourfathollah AA; Amini-Kafiabad S; Karimian MS; Rahimzadeh P; Salehifar P
    Transfus Clin Biol; 2023 Nov; 30(4):417-420. PubMed ID: 37544584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemovigilance drives improved transfusion safety.
    Murphy MF
    Transfusion; 2021 Apr; 61(4):1333-1335. PubMed ID: 33831223
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood safety in Mexico and a perspective on Latin America.
    Novelo-Garza B; Duque-Rodríguez J; Mejía-Domínguez AM; Rivas-González MR; Torres-Torres O
    Transfus Apher Sci; 2019 Dec; 58(6):102661. PubMed ID: 31757664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].
    Laperche S
    Transfus Clin Biol; 1998 Apr; 5(2):139-46. PubMed ID: 9618839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico.
    Sánchez-González G; Figueroa-Lara A; Elizondo-Cano M; Wilson L; Novelo-Garza B; Valiente-Banuet L; Ramsey JM
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004528. PubMed ID: 27002523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period.
    Balint B; Vucetic D; Todorovic-Balint M; Borovcanin N; Jovanovic-Cupic S; Mandusic V
    Transfus Apher Sci; 2013 Aug; 49(1):103-4. PubMed ID: 23820432
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
    Stramer SL; Notari EP; Krysztof DE; Dodd RY
    Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of quality rapid diagnostic testing for safe blood transfusion in resource-limited settings.
    Mbanya D
    Clin Microbiol Infect; 2013 May; 19(5):416-21. PubMed ID: 23464853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B infection and transfusion-transmission risk.
    Candotti D; Boizeau L; Laperche S
    Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood Safety in the XXI century. Transfusion transmitted infectious diseases. International and Mexican view].
    Rojo Medina J
    Gac Med Mex; 2014; 150(1):78-83. PubMed ID: 24481434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogen reduction combined with rapid diagnostic tests to reduce the risk of transfusion-transmitted infections in Uganda.
    Butler EK; McCullough J
    Transfusion; 2018 Apr; 58(4):854-861. PubMed ID: 29405306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction.
    Shander A
    Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):1-3. PubMed ID: 23590910
    [No Abstract]   [Full Text] [Related]  

  • 19. The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries.
    O'Brien SF; Delage G; Seed CR; Pillonel J; Fabra CC; Davison K; Kitchen A; Steele WR; Leiby DA
    Transfus Med Rev; 2015 Jul; 29(3):162-71. PubMed ID: 25933591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead.
    Dean CL; Wade J; Roback JD
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29669792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.